Produktinformation
Tetraglyme-d6 is a medicinal compound that has been developed as an analog of a protein kinase inhibitor. This compound has shown potent anticancer activity in human cancer cells and has been found to induce apoptosis, or programmed cell death, in tumor cells. Tetraglyme-d6 inhibits the activity of kinases, which are enzymes that play a critical role in the regulation of cellular processes such as growth and division. This inhibition leads to the suppression of cancer cell growth and proliferation. The compound has been tested extensively in Chinese hamster ovary cells and its efficacy as an anticancer agent has been demonstrated in vivo. Furthermore, it has also been detected in urine samples from patients with cancer who have received treatment with this inhibitor. Tetraglyme-d6 is a promising candidate for further development as a potent anticancer drug.
Chemische Eigenschaften
Technische Anfrage zu: 3D-RYB62815 Tetraglyme-d6
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
